Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis

Journal of Clinical Neurology (Korea)

Volumn 9, Issue 3, 2013, Pages 165-175

  Musialek, Piotr ^a,c   Tracz, Wieslawa ^a,c   Tekieli, Lukasz ^a,c   Pieniazek, Piotr ^a,c   Kablak Ziembicka, Anna ^a,c   Przewlocki, Tadeusz ^a,c   Stepien, Ewa ^b   Kapusta, Przemyslaw ^c   Motyl, Rafal ^c,d   Stepniewski, Jakub ^a,c   Undas, Anetta ^b,c   Podolec, Piotr ^a,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^d Center of Clinical Neurology   (Poland)

Author keywords

Biomarkers; Carotid artery stenosis; Circulating cytokines; Hdl cholesterol; Risk factors; Stroke risk

Indexed keywords

EID: 84880081944     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2013.9.3.165     Document Type: Article

References (48)

1. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Ch-aturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517-584.
2. Kim JT, Yoo SH, Kwon JH, Kwon SU, Kim JS. Subtyping of ischemic stroke based on vascular imaging: analysis of 1,167 acute, consecutive patients. J Clin Neurol 2006;2:225-230.
3. Halliday A, Harrison M, Hayter E, Kong X, Mansfeld A, Marro J, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010;376:1074-1084.
4. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007;27:15-26.
5. Alvarez Garcia B, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 2003;38:1018-1024.
6. Heo SH, Cho CH, Kim HO, Jo YH, Yoon KS, Lee JH, et al. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol 2011;7:69-76.
7. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in Inflammation and plaque destabilization. Circulation 2007;115:972-980.
8. Mannheim D, Herrmann J, Versari D, Gössl M, Meyer FB, McConnell JP, et al. Enhanced expression of Lp-PLA2 and lysophosphatidylcho-line in symptomatic carotid atherosclerotic plaques. Stroke 2008;39: 1448-1455.
9. Urbonaviciene G, Frystyk J, Flyvbjerg A, Henneberg EW, Lindholt JS. Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease. Atherosclerosis 2010;210: 619-624.
10. Golledge J, McCann M, Mangan S, Lam A, Karan M. Osteoprote-gerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 2004;35:1636-1641.
11. Bornstein N, Korczyn A. Asymptomatic carotid artery stenosis (AC-AS). J Neural Transm 2011;118:629.
12. Cola C, Clementi E, Biondi-Zoccai G, Sangiorgi G. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events. Acta Chir Belg 2007;107:129-142.
13. Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT. Infammatory and non-invasive vascular markers: the multi-marker approach for risk stratifcation in coronary artery disease. Atherosclerosis 2008;199:3-11.
14. Pieniazek P, Musialek P, Dzierwa K, Motyl R, Trystuła M, Przewlocki T, et al. Flow reversal for proximal neuroprotection during endovascu-lar management of critical symptomatic carotid artery stenosis coexisting with ipsilateral external carotid artery occlusion. J Endovasc Ther 2009;16:744-751.
15. Kablak-Ziembicka A, Przewlocki T, Sokołowski A, Tracz W, Podolec P. Carotid intima-media thickness, hs-CRP and TNF-α are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis 2011;214:185-190.
16. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-2906.
17. Musialek P, Pieniazek P, Tracz W, Tekieli L, Przewlocki T, Kablak-Ziembicka A, et al. Safety of embolic protection device-assisted and unprotected intravascular ultrasound in evaluating carotid artery atherosclerotic lesions. Med Sci Monit 2012;18:MT7-MT18.
18. Kwee RM, van Oostenbrugge RJ, Mess WH, Prins MH, van der Geest RJ, ter Berg JW, et al. Carotid plaques in transient ischemic attack and stroke patients: one-year follow-up study by magnetic resonance imaging. Invest Radiol 2010;45:803-809.
19. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004;29:439-493.
20. Liapis CD, Bell PR, Mikhailidis D, Sivenius J, Nicolaides A, Fernandese Fernandes J, et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 2009;37(4 Suppl):1-19.
21. Koutouzis M, Rallidis LS, Peros G, Nomikos A, Tzavara V, Barbatis C, et al. Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease. Acta Neurol Scand 2009;119:119-125.
22. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, et al. Relationships among regional arterial Inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging 2009;2:107-115.
23. Higashikata T, Yamagishi M, Higashi T, Nagata I, Iihara K, Miyamoto S, et al. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method. Atherosclerosis 2006;185:165-172.
24. Stepień E, Fedak D, Klimeczek P, Wilkosz T, Banyś RP, Starzyk K, et al. Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects. Hypertens Res 2012;35: 531-538.
25. Peeters W, Hellings WE, de Kleijn DP, de Vries JP, Moll FL, Vink A, et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol 2009;29:128-133.
26. Sabeti S, Exner M, Mlekusch W, Amighi J, Quehenberger P, Rumpold H, et al. Prognostic impact of fibrinogen in carotid atherosclerosis: non-specific indicator of inflammation or independent predictor of disease progression? Stroke 2005;36:1400-1404.
27. Montecucco F, Lenglet S, Gayet-Ageron A, Bertolotto M, Pelli G, Pal-ombo D, et al. Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 2010; 41:1394-1404.
28. Pelisek J, Rudelius M, Zepper P, Poppert H, Reeps C, Schuster T, et al. Multiple biological predictors for vulnerable carotid lesions. Cerebro-vasc Dis 2009;28:601-610.
29. Milei J, Parodi JC, Ferreira M, Barrone A, Grana DR, Matturri L. Atherosclerotic plaque rupture and intraplaque hemorrhage do not correlate with symptoms in carotid artery stenosis. J Vasc Surg 2003;38: 1241-1247.
30. Mauriello A, Sangiorgi GM, Virmani R, Trimarchi S, Holmes DR Jr, Kolodgie FD, et al. A pathobiologic link between risk factors profile and morphological markers of carotid instability. Atherosclerosis 2010; 208:572-580.
31. Lombardo A, Biasucci LM, Lanza GA, Coli S, Silvestri P, Cianfone D, et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004;109:3158-3163.
32. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient--Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006;98:2H-15H.
33. Krupinski J, Turu MM, Martinez-Gonzalez J, Carvajal A, Juan-Babot JO, Iborra E, et al. Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 2006;37:1200-1204.
34. Turu MM, Krupinski J, Catena E, Rosell A, Montaner J, Rubio F, et al. Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2006;187: 161-169.
35. Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ. Carotid plaque formation and serum biomarkers. Atherosclerosis 2010;213: 21-29.
36. Debing E, Peeters E, Demanet C, De Waele M, Van den Brande P. Markers of Inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: a case-control study. Vasc Endovascular Surg 2008;42:122-127.
37. Yamagami H, Sakaguchi M, Furukado S, Hoshi T, Abe Y, Hougaku H, et al. Statin therapy increases carotid plaque echogenicity in hyper-cholesterolemic patients. Ultrasound Med Biol 2008;34:1353-1359.
38. Horiuchi Y, Hirayama S, Soda S, Seino U, Kon M, Ueno T, et al. Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels. J Atheroscler Thromb 2010;17:722-729.
39. Seo SM, Choo EH, Koh YS, Park MW, Shin DI, Choi YS, et al. High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention. Heart 2011;97:1943-1950.
40. Gielen S, Landmesser U. A new look at HDL in coronary disease: can we escape natural history? Heart 2011;97:1899-1901.
41. Laloux P, Galanti L, Jamart J. Lipids in ischemic stroke subtypes. Acta Neurol Belg 2004;104:13-19.
42. Johnsen SH, Mathiesen EB, Fosse E, Joakimsen O, Stensland-Bugge E, Njølstad I, et al. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study. Circulation 2005;112:498-504.
43. Kim DE, Kim J Y, Jeong SW, Cho YJ, Park JM, Lee JH, et al. Association between changes in lipid profles and progression of symptomatic intracranial atherosclerotic stenosis: a prospective multicenter study. Stroke 2012;43:1824-1830.
44. Kurebayashi N, Yoshikawa D, Ishii H, Sato B, Ando H, Okada T, et al. Impact of the low- to high-density lipoprotein cholesterol ratio on composition of angiographically ambiguous left main coronary artery plaque. Circ J 2011;75:1960-1967.
45. Kim DE, Kim JY, Schellingerhout D, Kim EJ, Kim HK, Lee S, et al. Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging. Arterioscler Thromb Vasc Biol 2010;30:449-456.
46. Kim JY, Park JH, Jeong SW, Schellingerhout D, Park JE, Lee DK, et al. High levels of remnant lipoprotein cholesterol is a risk factor for large artery atherosclerotic stroke. J Clin Neurol 2011;7:203-209.
47. Przewłocki T, Kabłak-Ziembicka A, Kozanecki A, Rzeźnik D, Pien-iazek P, Musiałek P, et al. Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease. Kardiol Pol 2009;67: 978-984.
48. Park KY, Youn YC, Chung CS, Lee KH, Kim GM, Chung PW, et al. Large-artery stenosis predicts subsequent vascular events in patients with transient ischemic attack. J Clin Neurol 2007;3:169-174.